
Bombay Oxygen Investments Q1 FY27 Results: Revenue Rs 33 Cr, PAT Rs 28 Cr and Key Highlights
Bombay Oxygen Investments Q1 FY27: Revenue Rs 33 Cr (+16.48% YoY). PAT Rs 28 Cr (+17.71% YoY). Results announced Aug 10, 2026. CMP Rs 19,779.95.
Updated: 11 Aug 2026 • 12:00 pm
Posted by:

Bombay Oxygen Investments Q1 FY27 results were announced on August 10, 2026, with the financial holdings company reporting a net profit (PAT) of Rs 28 crore, up 17.71% from Rs 24 crore in Q1 FY26. Revenue from operations in the Bombay Oxygen Investments Q1 FY27 results rose 16.48% year on year to Rs 33 crore from Rs 28 crore in Q1 FY26. These Bombay Oxygen Investments Q1 FY27 results are on a standalone basis for the quarter ended June 30, 2026.
Click Here – Get Free Investment Predictions
Bombay Oxygen Investments Q1 FY27 Financial Highlights
The table below presents the key financial metrics from the Bombay Oxygen Investments Q1 FY27 results compared with the corresponding quarter of the previous year.
| Metric | Q1 FY27 (Jun 2026) | Q1 FY26 (Jun 2025) | YoY Change |
|---|---|---|---|
| Revenue from Operations (Rs Cr) | Rs 33 Cr | Rs 28 Cr | +16.48% |
| Gross Profit (Rs Cr) | Rs 33 Cr | Rs 28 Cr | +16.68% |
| Net Profit / (Loss) – PAT (Rs Cr) | Rs 28 Cr | Rs 24 Cr | +17.71% |
Bombay Oxygen Investments Q1 FY27 Performance Analysis
Use the Univest Screener to Track Live Fundamentals of Indian Stocks
The Bombay Oxygen Investments Q1 FY27 results show revenue growth of 16.48% year on year to Rs 33 crore. Gross profit improved to Rs 33 crore from Rs 28 crore in Q1 FY26.
Net profit in the Bombay Oxygen Investments Q1 FY27 results stood at Rs 28 crore, up 17.71% from Rs 24 crore in Q1 FY26. Investors tracking the Bombay Oxygen Investments Q1 FY27 results should verify these figures against the official BSE and NSE filings for accuracy.
Key Business Factors in Bombay Oxygen Investments Q1 FY27
1. Revenue Growth Drove Top-Line Expansion
The Bombay Oxygen Investments Q1 FY27 results show revenue growing 16.48% year on year to Rs 33 crore. The improvement reflects stronger demand or expanded operations within the Financial Holdings segment during the June 2026 quarter.
2. Gross Profit Momentum Supported Margins
Gross profit in the Bombay Oxygen Investments Q1 FY27 results improved to Rs 33 crore from Rs 28 crore in Q1 FY26, a gain of 16.68%.
3. Net Profit Improvement in Q1 FY27
The Bombay Oxygen Investments Q1 FY27 results delivered a net profit (PAT) of Rs 28 crore, up 17.71% from Rs 24 crore in Q1 FY26. This profit improvement reflects the company's improving operational leverage in the Financial Holdings space.
Dividend Details
No dividend has been declared alongside the Bombay Oxygen Investments Q1 FY27 results for the quarter ended June 2026. Investors may track any future dividend announcements via BSE India and NSE India.
Bombay Oxygen Investments FY27 Outlook After Q1 Results
The Bombay Oxygen Investments Q1 FY27 results set a broadly positive tone for the full financial year. Revenue growth of 16.48% and a net profit (PAT) of Rs 28 crore provide a foundation for further improvement. Investors tracking the Bombay Oxygen Investments Q1 FY27 results should monitor demand conditions in the Financial Holdings sector, input cost movements, and any capacity or business expansion plans that could drive earnings through the remainder of FY27.
Bombay Oxygen Investments Stock Performance
Download the Univest iOS App or Univest Android App to track Bombay Oxygen Investments live share price and upcoming quarterly results.
Bombay Oxygen Investments share price stood at Rs 19,779.95 on August 10, 2026, the day the Bombay Oxygen Investments Q1 FY27 results were declared. Post-results, the market will assess whether the Financial Holdings company's financial performance justifies the current valuation. Investors should verify the latest price and fundamentals before making any decision.
Key Risks to Watch After Bombay Oxygen Investments Q1 FY27 Results
1. Sector-Specific Demand Headwinds
A slowdown in the Financial Holdings sector could affect Bombay Oxygen Investments revenue and profitability beyond what the Q1 FY27 results currently indicate.
2. Input Cost and Margin Pressure
Rising raw material or operational costs could compress gross margins and limit net profit improvement in subsequent quarters of FY27.
3. Macroeconomic and Regulatory Uncertainty
Broader macroeconomic headwinds including inflation, interest rate changes, and regulatory shifts remain key risks to the FY27 earnings outlook for Bombay Oxygen Investments.
Conclusion
The Bombay Oxygen Investments Q1 FY27 results report revenue of Rs 33 crore and a net profit (PAT) of Rs 28 crore, up 17.71% from Rs 24 crore in Q1 FY26. The Bombay Oxygen Investments Q1 FY27 results reflect the company's operational position in the Financial Holdings sector for the June 2026 quarter. Investors should study the complete financials available on BSE and NSE and consult a SEBI-registered advisor before making any investment decision.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions on Bombay Oxygen Investments Q1 FY27 Results
When were the Bombay Oxygen Investments Q1 FY27 results announced?
Ans. The Bombay Oxygen Investments Q1 FY27 results were announced on August 10, 2026, covering the quarter ended June 30, 2026. The standalone results were filed with BSE and NSE on the same date.
What is the PAT in the Bombay Oxygen Investments Q1 FY27 results?
Ans. PAT (net profit) stood at Rs 28 crore in the June 2026 quarter, up 17.71% from Rs 24 crore in Q1 FY26.
What was the revenue in the Bombay Oxygen Investments Q1 FY27 results?
Ans. Revenue for the June 2026 quarter rose 16.48% year on year to Rs 33 crore from Rs 28 crore in Q1 FY26.
Did Bombay Oxygen Investments declare any dividend along with Q1 FY27 results?
Ans. No dividend has been declared with the Bombay Oxygen Investments Q1 FY27 results for the June 2026 quarter. Investors may track future dividend announcements through the BSE and NSE portals.
What is the Bombay Oxygen Investments outlook for FY27 after Q1 results?
Ans. The June 2026 quarter data signals a positive start to FY27 for Bombay Oxygen Investments. Key factors to watch include revenue trends, margin performance, and sector developments through the rest of the financial year.
Is Bombay Oxygen Investments a good investment after Q1 FY27 results?
Ans. The Q1 FY27 financial performance of Bombay Oxygen Investments shows improving trends. This article is for educational purposes only and does not constitute investment advice. Please consult a SEBI-registered investment advisor before making any investment decision.
Recent Articles

ID Info Business Services Ltd. (ICONIKSPEV): ID Info Business Services Share Price Rises 9.99% as Micro Cap Stock Gains Today
11 August 2026

Lloyds Metals & Energy Ltd. (LLOYDSME): Lloyds Metals & Energy Share Price Falls 3.27% Today; Stock in Focus
11 August 2026

Bansal Roofing Q1 FY27 Results: Revenue Rs 45 Cr, PAT Rs 2 Cr and Key Highlights
11 August 2026

Lotus Eye Care Q1 FY27 Results: Revenue Rs 17 Cr, PAT Rs 0.61 Cr and Key Highlights
11 August 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
ID Info Business Services Ltd. (ICONIKSPEV): ID Info Business Services Share Price Rises 9.99% as Micro Cap Stock Gains Today
Lloyds Metals & Energy Ltd. (LLOYDSME): Lloyds Metals & Energy Share Price Falls 3.27% Today; Stock in Focus
Bansal Roofing Q1 FY27 Results: Revenue Rs 45 Cr, PAT Rs 2 Cr and Key Highlights
Lotus Eye Care Q1 FY27 Results: Revenue Rs 17 Cr, PAT Rs 0.61 Cr and Key Highlights
West Leisure Resorts Q1 FY27 Results: Revenue Rs 0.04 Cr, PAT Rs 0.01 Cr and Key Highlights
Popular this week
Oxygenta Pharmaceutical Ltd. (OXYGENTAPH): Oxygenta Pharmaceutical Share Price Rises 20% as Stock Enters Top Gainers Today

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





